Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal methotrexate for persistent diabetic macular edema
IRCT201610098983N2Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methotrexate in diabetic macular edema (DME), sponsored by Guilan University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
methotrexate
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on IRCT201610098983N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201610098983N2.